As of close of business last night, Beam Therapeutics Inc’s stock clocked out at $37.53, up 1.54% from its previous closing price of $36.96. In other words, the price has increased by $+0.57 from its previous closing price. On the day, 662183 shares were traded. BEAM stock price reached its highest trading level at $38.97 during the session, while it also had its lowest trading level at $36.88.
Ratios:
To gain a deeper understanding of BEAM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.89 and its Current Ratio is at 5.89. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Upgraded its rating to Overweight and sets its target price to $40 from $38 previously.
On December 15, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $35.
Jefferies Downgraded its Buy to Hold on December 08, 2023, whereas the target price for the stock was revised from $75 to $30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 14 ’24 when FMR LLC sold 900,000 shares for $30.55 per share. The transaction valued at 27,496,912 led to the insider holds 1,235,511 shares of the business.
FMR LLC sold 1,565 shares of BEAM for $48,139 on Feb 13 ’24. The insider 1 now owns 2,771,913 shares after completing the transaction at $30.76 per share. On Jan 31 ’24, another insider, Evans John M., who serves as the CEO of the company, sold 60,000 shares for $25.33 each. As a result, the insider received 1,519,800 and left with 1,058,262 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 3.06B and an Enterprise Value of 2.05B. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.11 while its Price-to-Book (P/B) ratio in mrq is 3.12. Its current Enterprise Value per Revenue stands at 5.42 whereas that against EBITDA is -13.07.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $16.95. The 50-Day Moving Average of the stock is 30.00, while the 200-Day Moving Average is calculated to be 27.79.
Shares Statistics:
It appears that BEAM traded 1.47M shares on average per day over the past three months and 1.99M shares per day over the past ten days. A total of 81.63M shares are outstanding, with a floating share count of 67.93M. Insiders hold about 16.81% of the company’s shares, while institutions hold 76.98% stake in the company. Shares short for BEAM as of Feb 15, 2024 were 13.43M with a Short Ratio of 9.15, compared to 13.13M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.46% and a Short% of Float of 20.86%.
Earnings Estimates
As of right now, 12 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1.39 for the current quarter, with a high estimate of -$1 and a low estimate of -$2.16, while EPS last year was -$1.33. The consensus estimate for the next quarter is -$1.36, with high estimates of -$1 and low estimates of -$2.19.
Analysts are recommending an EPS of between -$3.98 and -$8.85 for the fiscal current year, implying an average EPS of -$5.31. EPS for the following year is -$5.05, with 12 analysts recommending between -$3.47 and -$5.85.
